Abstract |
|
Authors | R A Janknegt, C C Abbou, R Bartoletti, L Bernstein-Hahn, B Bracken, J M Brisset, F C Da Silva, G Chisholm, E D Crawford, F M Debruyne |
Journal | The Journal of urology
(J Urol)
Vol. 149
Issue 1
Pg. 77-82; discussion 83
(Jan 1993)
ISSN: 0022-5347 [Print] United States |
PMID | 7678043
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Imidazoles
- Imidazolidines
- nilutamide
- Acid Phosphatase
- Prostate-Specific Antigen
|
Topics |
- Acid Phosphatase
(blood)
- Actuarial Analysis
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(adverse effects, therapeutic use)
- Bone Neoplasms
(secondary)
- Combined Modality Therapy
- Double-Blind Method
- Follow-Up Studies
- Humans
- Imidazoles
(adverse effects, therapeutic use)
- Imidazolidines
- Male
- Middle Aged
- Orchiectomy
(adverse effects)
- Prostate
- Prostate-Specific Antigen
(blood)
- Prostatic Neoplasms
(blood, mortality, pathology, therapy)
- Survival Analysis
|